Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization
Citation
Crowley E, Griffiths AM, Jairath V; pIBD CLINICAL TRIALS OUTCOME GROUP. Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization. Gastroenterology. 2022 Nov;163(5):1137-1144. doi: 10.1053/j.gastro.2022.07.006. Epub 2022 Jul 16. PMID: 35850191.
Tags
Clinical Trials, Diagnosis, Drug Therapy, IBD, Inflammatory Bowel Disease, Pediatrics
Join us at the DDW Tradeshow to explore Alimentiv’s groundbreaking research showcased across six posters and two podium presentations. View our full lineup.